MedTrace Logo

Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation

NCT01389115 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2015-12-11

No results posted yet for this study

Summary

The purpose of this study is to determine lipid metabolism in chronic liver disease in the attempt to find a useful biomarker of liver function and of prognostic value of graft function in those patients who undergo liver transplant. The present study enrolls subjects with liver cirrhosis (with different ethiology), including subjects eligible for a full-size liver transplantation, and healthy controls.

Conditions

Sponsors & Collaborators

  • University of Roma La Sapienza

    lead OTHER

Principal Investigators

  • Stefano Corradini, M.D., Ph.D. · University of Roma La Sapienza

Eligibility

Min Age
15 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-07-31
Primary Completion
2016-05-31
Completion
2016-09-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01389115 on ClinicalTrials.gov